More Medical Developments International Limited news
Medical Developments International LimitedASX: MVP

Penthrox Marketing Authorisation Application in Russia

Dec 6, 2019 at 12:27 AM EST · Issued by Medical Developments International Limited

Filed with ASX · Dec 6, 2019 at 12:27 AM EST · 2 pages · English

On 6ix: 6ix.com/news/penthrox-marketing-authorisation-application-in-russia

Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19↗

Medical Developments International Limited on 6ix

Story so far

  • Penthrox Licensing Deal for RussiaApr 12, 2017

Earlier from Medical Developments International

  • Penthrox IND approved in ChinaNov 20, 2019
  • CEO Roadshow PresentationOct 30, 2019
  • Chairmans Address to ShareholdersOct 30, 2019
  • MVP signs new Manufacturing Development Project with CSIROOct 28, 2019
  • Penthrox approved in EUSEM guidelinesOct 23, 2019

Later from Medical Developments International

  • FY20 HY Report and AccountsFeb 18, 2020
  • MVP announces leadership changeMar 4, 2020
  • COVID-19 Impact on MVPMar 17, 2020
  • Penthrox is approved in ThailandApr 27, 2020
  • Penthrox approved - Netherlands and Bosnia and HerzegovinaMay 4, 2020
All Medical Developments International news releases↗

Follow Medical Developments International into a list and get an email when it puts out news.

Follow Medical Developments International
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer